13F Holdings
中文EN

XTNT Xtant Medical Holdings, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1453593 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-24.4%
TTM net income YoY-1,014.2%
TTM EPS YoY-1,200.0%
Revenue 3-yr CAGR8.6%
Net income 3-yr CAGR—

Margins

Gross margin56.4%
Operating margin-16.0%
Net margin-15.9%
FCF margin-6.1%
EBITDA margin-12.6%

Returns

ROE-36.5%
ROA-17.6%
ROIC (approx.)-26.2%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets50.5%
Debt / equity0.27x
Current ratio2.00x
Interest coverage-6.56x

Cash quality & payout

Operating cash flow / net income0.31x
Accruals ratio-12.2%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$133.93M$117.27M$91.30M$57.97M$55.26M
Cost of revenue$49.65M$49.05M$35.84M$25.83M$22.77M
Gross profit$84.27M$68.22M$55.47M$32.14M$32.49M
R&D expense$2.10M$2.38M$1.34M$915,000$870,000
SG&A expense$29.38M$28.69M$25.85M$15.46M$14.45M
Operating income$7.28M-$12.07M-$10.16M-$6.75M-$3.85M
Interest expense$3.67M$4.16M$2.94M$1.69M$995,000
Pretax income$7.00M-$16.26M-$1.04M-$8.42M-$4.85M
Income tax$2.03M$187,000-$1.70M$69,000—
Net income$4.97M-$16.45M$660,000-$8.48M-$4.85M
EBITDA$12.51M-$7.85M-$6.98M-$5.46M-$2.52M
EPS (basic)0.04-0.120.01-0.09-0.06
EPS (diluted)0.03-0.120.01-0.09-0.06
Weighted avg. shares (diluted)150.04M133.67M126.79M94.09M85.46M
Balance sheet
Cash & equivalents$17.05M$6.20M$5.71M$20.30M$18.24M
Receivables$17.80M$20.66M$21.70M$10.85M$7.15M
Inventory$30.26M$38.63M$36.88M$17.29M$17.95M
Current assets$78.25M$67.12M$64.87M$49.32M$44.33M
PP&E, net$6.20M$10.13M$8.69M$5.79M$5.21M
Goodwill$6.07M$7.30M$7.30M$3.21M$3.21M
Intangibles$299,000$8.36M$10.09M$344,000$400,000
Total assets$94.14M$93.84M$92.61M$60.23M$54.69M
Current liabilities$29.48M$28.58M$22.99M$15.22M$11.08M
Short-term debt$3.50M——$2.33M—
Long-term debt$11.03M$22.04M$17.17M$9.69M$11.79M
Total debt$14.53M$22.04M$17.17M$12.02M$11.79M
Total liabilities$43.19M$50.87M$41.26M$26.06M$23.81M
Shareholders' equity$50.95M$42.96M$51.35M$34.17M$30.88M
Net debt-$2.53M$15.84M$11.45M-$8.28M-$6.46M
Shares outstanding140.04M139.05M130.18M108.87M87.07M
Cash flow statement
Operating cash flow$12.55M-$11.90M-$9.52M-$5.34M$439,000
Capital expenditure$2.38M$4.11M$1.46M$1.76M$2.12M
Free cash flow$10.16M-$16.01M-$10.97M-$7.11M-$1.68M
Investing cash flow$7.90M-$3.73M-$24.78M-$1.56M-$1.89M
Financing cash flow-$9.57M$16.07M$19.69M$9.02M$17.50M
Depreciation & amortization$5.22M$4.22M$3.17M$1.29M$1.33M
Stock-based compensation$2.89M$4.12M$2.74M$2.46M$2.21M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.